U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269743) titled 'TO OBSERVE PRACTISE PATTERN OF AEROSOL THERAPY IN ARDS PATIENTS (AERO-IN-ARDS)' on Nov. 25.
Brief Summary: Aerosol therapy delivers medicines as a fine mist directly into the lungs. This allows faster action and fewer whole-body side effects. It is a key treatment for diseases such as asthma and COPD. In acute respiratory distress syndrome (ARDS), early laboratory and small clinical studies suggested that inhaled beta-2 agonists and corticosteroids might help the lungs heal by improving mucus clearance, reducing inflammation, and helping remove excess fluid. However, larger randomized trials have not shown clear clinical benefits. Th...